[Federal Register Volume 83, Number 218 (Friday, November 9, 2018)]
[Notices]
[Pages 56103-56104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24485]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Chattem 
Chemicals

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 8, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    The Attorney General has delegated his authority under the 
Controlled Substances Act to the Administrator of the Drug Enforcement 
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all 
necessary functions with respect to the promulgation and implementation 
of 21 CFR part 1301, incident to the registration of manufacturers, 
distributors, dispensers, importers, and exporters of controlled 
substances (other than final orders in connection with suspension, 
denial, or revocation of registration) has been redelegated to the 
Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on August 
2, 2018, Chattem Chemicals, 3801 Saint Elmo Avenue, Chattanooga, 
Tennessee 37409-1237 applied to be registered as a bulk manufacturer of 
the following basic classes of controlled substances:

 
------------------------------------------------------------------------
      Controlled substance           Drug code           Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......            2010  I
Marihuana.......................            7360  I
Tetrahydrocannabinols...........            7370  I
4-Methoxyamphetamine............            7411  I
Dihydromorphine.................            9145  I
Amphetamine.....................            1100  II
Methamphetamine.................            1105  II
Lisdexamfetamine................            1205  II
Methylphenidate.................            1724  II
Codeine.........................            9050  II
Dihydrocodeine..................            9120  II
Oxycodone.......................            9143  II
Hydromorphone...................            9150  II
Hydrocodone.....................            9193  II
Levorphanol.....................            9220  II
Methadone.......................            9250  II
Methadone intermediate..........            9254  II
Morphine........................            9300  II
Oripavine.......................            9330  II
Thebaine........................            9333  II
Oxymorphone.....................            9652  II
Noroxymorphone..................            9668  II

[[Page 56104]]

 
Tapentadol......................            9780  II
Fentanyl........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution and sale to its customers.
    In reference to drug code 7360 (marihuana) and 7370 
(tetrahydrocannabinols) the company plans to bulk manufacture these 
drugs as synthetic. No other activities for these drug codes are 
authorized for this registration.

    Dated: October 25, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-24485 Filed 11-8-18; 8:45 am]
 BILLING CODE 4410-09-P